MehlingMBrinkmannVAntelJ. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology2008; 71: 1261–1267.
2.
CohenJABarkhofFComiG.; TRANSFORMS Study Group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med2010; 362: 402–415.
3.
GkolfinopoulouKBitsolasNPatrinosS. Epidemiology of human leishmaniasis in Greece, 1981–2011. Euro Surveill2013; 18: 20532.
4.
WilsonMEJeronimoSMPearsonRD. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog2005; 38: 147–160.
5.
M OpataMStephensR. Early decision: Effector and effector memory T cell differentiation in chronic infection. Curr Immunol Rev2013; 9: 190–206.
